RecruitingNCT02300766
Cerebellar Mutism Syndrome Study
Nordic Study of the Cerebellar Mutism Syndrome in Children With Brain Tumours of the Posterior Fossa
Sponsor
Rigshospitalet, Denmark
Enrollment
1,000 participants
Start Date
Oct 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to determine why up to 25% of the pediatric patients who have surgery for a tumor in the posterior fossa develops the Cerebellar Mutism Syndrome (CMS). Furthermore the purpose is to explore the clinical course and the best treatment of the syndrome.
Eligibility
Max Age: 18 Years
Inclusion Criteria3
- Age \< 18 years at the date of first imaging showing this tumour
- Tumour in the cerebellum/4th ventricle/brainstem with intention to treat with surgical resection or open biopsy. Second and further surgeries are also included.
- Informed consent from custodial parent(s)
Exclusion Criteria1
- None
Locations(30)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02300766